Why everyone is analysing daily moves under the microscope is beyond me. People buy , people sell people watch and wait. makes no odds, this will be much higher in six months and we all know that.
Regarding strategy LTB&H has served Mr. Buffet well over the years. Buying into a growing company that pays a growing dividend that is reinvested to gain more dividend will beat a trader over the long term. When warren challenged an actively managed hedge fund not that long ago he won the bet and made even more dosh. Charts in hindesight always show good entry and exit points but not easy in real time.
Be careful when comparing Parsortix with Cellsearch. When granted Parsortix will be the only device ever cleared by FDA to "Harvest" CTC's for subequent analysis. Cellcearch cannot harvest viable cells. That's a major difference and to be the only device in the world approved to harvest rare CTC's will be worth quite a bit.
AN's target is not £4 it's $5b for the company so with the present number of shares that equates to around £17 per share. I'd settle for half that myself!
They are planning ahead. In business it is always easier to raise cash when you don't need it . If you try to do it when you need it you are over a barrel and get shafted. Cash is King.